Background: This experimental study examined the trends of the antioxidant drug "U-74389G", on a rat model and particularly in a hypoxia -reoxygenation (HR) protocol. The trends of that molecule were studied biochemically using blood mean potassium levels.
Methods: 40 rats of mean weight 231.875 g were used in the study. Potassium (K + ) levels were measured at 60 min of reoxygenation (groups A and C) and at 120 min of reoxygenation (groups B and D) with administration of the drug U-74389G in groups C and D.

Results: U-74389G administration non significantly decreased the K + levels by 2.14%+5.06% (p= 0.6730). Reoxygenation time non-significantly increased the K + levels by 8.66%+4.85% (p= 0.0934). However, U-74389G administration and reoxygenation time together non-significantly increased the K + levels by 2.07%+3.03% (P= 0.4853).
Conclusions: U-74389G administration, reoxygenation time and their interaction have miscellaneous non significant short -term trends on potassium levels. Perhaps, a longer study time or a higher drug dose may reveal clearer and significant effects.
IntroductIon P ermanent or transient damage with serious implications on adjacent organs and systems may be due to tissue hypoxia reoxygenation (HR). The use of U-74389G in HR has been a challenge for many years. However, although the progress was significant, several practical questions have not been clarified yet. They include: a) how potent U-74389G should be b) when should it be administered and c) at what optimal dose U-74389G should be administered. The promising effect of U-74389G in tissue protection has been noted in several HR studies. U-74389G or also known as 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-pregna-1,4,9(11)-triene-3,20-dione maleate salt is an antioxidant which prevents both arachidonic acid-induced and iron-dependent lipid peroxidation (1). It protects against HR injury in animal organs such as heart, liver and kidney models. These membrane-associating antioxidants are particularly effective in preventing permeability changes in brain microvascular endothelial cells monolayers (2).
The aim of this experimental study was to evaluate the effect of U-74389G in a rat model of HR using mean blood potassium (K + ) levels. The certain protocol and dose height were determined by following ex-periments with favorable outcomes. Actually, Flessas I et al found (3) the U-74389G protective in many emergency clinical situations of intestinal IR. Bimpis A et al limited brain damage itself after (4) U-74389G administration. Tsaroucha AK et al (5) attenuated liver damage after U-74389G administration. Andreadou I et al protected the small intestine (6) after U-74389G administration. Along, ovarian TNFa and malondialdehyde levels were evaluated at the same endpoints. The levels of TNFa were stayed rather undisturbed; whereas the malondialdehyde levels were kept significantly increased. Nevertheless, the recommendation was that these 2 body mass related biomarkers not to be considered because they were not representative of all tissues under the ischemia level. Contrary, potassium is a systemic variable concerning all these tissues and not only the ovaries. The consequence of the applied treatment was the investigation of the short-term trends of U-74389G on general metabolism and certainly whether it is anabolic or catabolic. Table 1 depicts that after the evaluation of 18 seric variables, the shost-term trend of the drug is rather catabolic; without the potassium trend included. This table was built-up by the successive stepwise addition of published studies (7-9). Although the addition of every variable was incidental, it seems that the profil of the table and generally of the drug is improbable to change, as many other variables even if be added. Inc. S.A. at Pikermi, Attiki. Accepted standards of humane animal care were adopted for Albino female Wistar rats. 7 days pre-experimental normal housing included ad libitum diet in laboratory. Post-experimental awakening and preservation of animals was not permitted even if euthanasia was required. Rats were randomly delivered to four experimental groups by 10 animals in each one, using following protocols of HR: Hypoxia for 45 min followed by reoxygenation for 60 min (group A). Hypoxia for 45 min followed by reoxygenation for 120 min (group B). Hypoxia for 45 min followed by immediate U-74389G intravenous (IV) administration and reoxygenation for 60 min (group C). Hypoxia for 45 min followed by immediate U-74389G IV administration and reoxygenation for 120 min (group D). The molecule U-74389G dosage was 10 mg/Kg body weight of animals.
Prenarcosis preceded of continuous intra-experimental general anesthesia, oxygen supply, electrocardiogram and The trends of the antioxidant drug "U-74389G" on potassium levels during hypoxia reoxygenation injury in rats C. Tsompos et al.
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acidometry. Hypoxia was caused by laparotomic clamping inferior aorta over renal arteries with forceps for 45 min. Reoxygenation was induced by removing the clamp and reestablishment the inferior aorta patency. After exclusion of blood flow, the protocol of HR was applied, as described above for each experimental group. U-74389G was administered at the time of reoxygenation through inferior vena cava catheter. The K + levels were determined at 60th min of reoxygenation (for A and C groups) and at 120th min of reoxygenation (for B and D groups). Fourty female Wistar albino rats were used (mean weight 231.875 g [standard deviation (SD): 36.59703 g], with minimum weight 165 g and maximum weight 320 g. Rats' weight could be potentially a confusing factor, e.g. more obese rats to have higher K levels. This assumption was also investigated. (Table 3 ). Any significant difference among K + levels, was investigated whether owed in probable significant weight correlations. 
The trends of the antioxidant drug "U-74389G" on potassium levels during hypoxia reoxygenation injury in rats
The generalized linear models (glm) with dependant variable the K + levels were applied. The 3 independent variables were the U-74389G or no drug, the reoxygenation time and both variables in combination. Inserting the rats' weight also as an independent variable at glm analysis, a non significant relation resulted in with K + levels (p=0.4029), so as to further investigation was not needed. dIscussIon Bibliography lacks references concerning whether hypoxia can influence the potassium levels. Potassium levels influence (10, 11) multiple physiological processes, includ- ing resting cellular-membrane potential and the propagation of action potentials in neuronal, muscular, and cardiac tissue (12) . Also K influences the hormone secretion and action, the vascular tone, controls the systemic blood pressure and the gastrointestinal motility. It joins in acidbase homeostasis, in glucose and insulin metabolism, in mineralocorticoid action, in renal concentrating ability and in fluid and electrolyte balance. Isolated potassium administration is impossible. The reason is that K + has a single electron in its outer electron shell, which readily gives it up to create an atom with a positive charge -a cation and oxidizes rapidly in air. After oxidation, it reacts vigorously with water combining with anions to form salts. Potassium occurs only in ionic salts usually associated with another drug or a factor. This last chemical conjugate probably influences the potassium occurrence. So, the administration of potassium is by means of a salt. Chiu PY et al associated (13) Also, K + levels are perhaps influenced by U-74389G administration. Stanimirovic DB et al abolished (24) the hydrogen peroxide-evoked decrease in Na,K-ATPase activity in presence of the steroid antioxidants U-74389G (5-20 μM) in rats cerebromicrovascular endothelial cells (RCEC). The oxidant-induced inhibition of Na,K-ATPase activity implicate the mechanism responsible for the delayed free radical-induced increase in RCEC membrane 'permeability'. conclusIon U-74389G administration, reoxygenation time and their interaction have miscellaneous non significant short -term trends on K + levels. Perhaps, a longer study time or a higher U-74389G dosage may reveal clearer and significant effects; including also an equal number of male rats for probable gender bias exclusion.
